The present disclosure relates to prosthetic heart valves and to methods and assemblies for attaching leaflets to a frame of the prosthetic heart valve with one or more connecting skirts.
The human heart can suffer from various valvular diseases. These valvular diseases can result in significant malfunctioning of the heart and ultimately require repair of the native valve or replacement of the native valve with an artificial valve. There are a number of known repair devices (e.g., stents) and artificial valves, as well as a number of known methods of implanting these devices and valves in humans. Percutaneous and minimally-invasive surgical approaches are used in various procedures to deliver prosthetic medical devices to locations inside the body that are not readily accessible by surgery or where access without surgery is desirable. In one specific example, a prosthetic heart valve can be mounted in a crimped state on the distal end of a delivery device and advanced through the patient's vasculature (e.g., through a femoral artery and the aorta) until the prosthetic valve reaches the implantation site in the heart. The prosthetic valve is then expanded to its functional size, for example, by inflating a balloon on which the prosthetic valve is mounted, actuating a mechanical actuator that applies an expansion force to the prosthetic valve, or by deploying the prosthetic valve from a sheath of the delivery device so that the prosthetic valve can self-expand to its functional size.
In some examples, the prosthetic heart valve can include a radially expandable and compressible frame comprising a plurality of struts and a valvular structure mounted within and to the frame. The valvular structure can comprise a plurality of leaflets. In some examples, a cusp edge portion of each leaflet can be secured to the frame with a connecting skirt that is attached to the leaflet. In such arrangements, struts of the frame that are disposed between cusp edge portions of adjacent leaflets can be uncovered by material of the leaflet and connecting skirt.
When the prosthetic heart valve is radially compressed onto and around the inflatable balloon of the delivery apparatus, the uncovered struts, which can include apices at an inflow end of the frame, can come into direct contact with the balloon. As a result, the uncovered struts and apices can cause abrasion or degradation to the balloon. In some examples, this can result in reduced or inadequate inflation of the balloon when attempting to deploy the prosthetic heart valve at an implantation site using the delivery apparatus.
Accordingly, a need exists for improved prosthetic heart valves and methods for assembling a valvular structure to a frame of a prosthetic heart valve which can result in reduced contact between struts of the frame and a balloon of a delivery apparatus when the prosthetic heart valve is radially compressed onto the delivery apparatus, around the balloon.
Described herein are examples of prosthetic heart valves including a frame and a valvular assembly arranged within and mounted to the frame and methods for assembling a prosthetic heart valve including a leaflet assembly. In some examples, the valvular assembly can comprise a plurality of leaflets, where each leaflet comprises opposing tabs on opposite sides of the leaflet and a cusp edge portion between the tabs. For each leaflet, the cusp edge portion can be connected to the frame by a connecting skirt. The connecting skirt can include a central portion, opposing side base portions on opposite sides of the central portion, and side extension portions that extend outward from respective side base portions. The central portion and opposing side base portions of the connecting skirt can be connected to each of the frame and the cusp edge portion of the leaflet and the side extension portions can extend across struts of the frame that are disposed between cusp edge portions of two adjacent leaflets.
In one representative example, a prosthetic heart valve comprises an annular frame comprising an inflow end and an outflow end and being radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration, wherein the frame comprises a plurality of struts. The prosthetic heart valve further comprises a valvular structure mounted within the frame and comprising a plurality of leaflets, wherein each leaflet comprises opposing tabs on opposite sides of the leaflet and a cusp edge portion between the tabs. The cusp edge portion of each leaflet is connected to the frame by a connecting skirt, wherein each connecting skirt comprises a central portion and opposing side base portions on opposite sides of the central portion that are connected to each of and disposed between the frame and the cusp edge portion of the leaflet, and wherein each connecting skirt further comprises side extension portions that extend outward from the cusp edge portion of the leaflet and across struts of the frame that are disposed between cusp edge portions of adjacent leaflets.
In another representative example, a prosthetic heart valve comprises an annular frame comprising an inflow end and an outflow end and being radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration, wherein the frame comprises a plurality of struts. The prosthetic heart valve further comprises a valvular structure mounted within the frame and comprising a plurality of leaflets, wherein each leaflet comprises opposing tabs on opposite sides of the leaflet and a cusp edge portion between the tabs, wherein each tab is paired with an adjacent tab of an adjacent leaflet to form a plurality of commissures that are connected to the frame. The prosthetic heart valve further comprises a plurality of connecting skirts, each connecting skirt comprising side base portions and a central portion connected to each of the cusp edge portion of a corresponding leaflet of the plurality of leaflets and struts of the frame, each connecting skirt further comprising side extension portions that extend outward and away from the cusp edge portion, wherein each side extension portion of each connecting skirt extends across struts of the frame, between cusp edge portions of adjacent leaflets and connects to an adjacent side extension portion of an adjacent connecting skirt.
In another representative example, a method of assembling a prosthetic heart valve comprising a plurality of leaflets, comprises forming a plurality of leaflet assemblies with the plurality of leaflets. Each leaflet assembly is formed by securing a central portion and side base portions of a connecting skirt to a cusp edge portion of a leaflet, wherein each connecting skirt comprises two side portions, one arranged on either side of the central portion, and wherein each side portion comprises a corresponding side base portion of the side base portions and a side extension portion extending outward and away from the corresponding side base portion. The method further comprises securing each connecting skirt to a frame of the prosthetic heart valve, the frame comprising a plurality of interconnected and angled struts, the securing including: securing the central portion and side base portions of the connecting skirt to a first portion of struts of the plurality of struts and extending each side extension portion of the connecting skirt across a second portion of struts of the plurality of struts that are disposed between cusp edge portions of adjacent leaflets and securing each side extension portion to an adjacent side extension portion of an adjacent connecting skirt.
In another representative example, a prosthetic heart valve comprises: an annular frame comprising an inflow end and an outflow end and being radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration, wherein the frame comprises a plurality of struts. The prosthetic heart valve further comprises a valvular structure mounted within the frame and comprising a plurality of leaflets, wherein each leaflet comprises opposing tabs on opposite sides of the leaflet and a cusp edge portion between the tabs, wherein each tab is paired with an adjacent tab of an adjacent leaflet to form a plurality of commissures that are connected to the frame. The prosthetic heart valve further comprises a plurality of connecting skirts, each connecting skirt comprising a base portion connected to each of the cusp edge portion of a corresponding leaflet of the plurality of leaflets and struts of the frame, each connecting skirt further comprising extension portions that extend outward and away from the cusp edge portion and cover inner surfaces of struts of the frame disposed between cusp edge portions of adjacent leaflets. The prosthetic heart valve further comprises an outer sealing member mounted around an outer surface of the frame and secured to the struts of the frame and the plurality of connecting skirts, the plurality of connecting skirts mounted around an inner surface of the frame.
The various innovations of this disclosure can be used in combination or separately. This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the detailed description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used to limit the scope of the claimed subject matter. The foregoing and other objects, features, and advantages of the disclosure will become more apparent from the following detailed description, claims, and accompanying figures.
For purposes of this description, certain aspects, advantages, and novel features of examples of this disclosure are described herein. The disclosed methods, apparatus, and systems should not be construed as being limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed examples, alone and in various combinations and sub-combinations with one another. The methods, apparatus, and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed examples require that any one or more specific advantages be present or problems be solved.
Although the operations of some of the disclosed examples are described in a particular, sequential order for convenient presentation, it should be understood that this manner of description encompasses rearrangement, unless a particular ordering is required by specific language set forth below. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods. Additionally, the description sometimes uses terms like “provide” or “achieve” to describe the disclosed methods. These terms are high-level abstractions of the actual operations that are performed. The actual operations that correspond to these terms may vary depending on the particular implementation and are readily discernible by one of ordinary skill in the art.
As used in this application and in the claims, the singular forms “a,” “an,” and “the” include the plural forms unless the context clearly dictates otherwise. Additionally, the term “includes” means “comprises.” Further, the term “coupled” generally means physically, mechanically, chemically, magnetically, and/or electrically coupled or linked and does not exclude the presence of intermediate elements between the coupled or associated items absent specific contrary language.
As used herein, the term “proximal” refers to a position, direction, or portion of a device that is closer to the user and further away from the implantation site. As used herein, the term “distal” refers to a position, direction, or portion of a device that is further away from the user and closer to the implantation site. Thus, for example, proximal motion of a device is motion of the device away from the implantation site and toward the user (e.g., out of the patient's body), while distal motion of the device is motion of the device away from the user and toward the implantation site (e.g., into the patient's body). The terms “longitudinal” and “axial” refer to an axis extending in the proximal and distal directions, unless otherwise expressly defined.
Described herein are examples of prosthetic heart valves, leaflet assemblies for prosthetic heart valves, connecting skirts, and methods for assembling leaflets assemblies and valvular structures to a frame of the prosthetic heart valve using one or more connecting skirts. The prosthetic heart valves can comprise a frame and a valvular structure attached to the frame, the valvular structure comprising a plurality of leaflets. In some examples, a connecting skirt can be secured to a cusp edge portion of a leaflet of the valvular structure. The portion of the connecting skirt secured to the cusp edge portion of the leaflet can then be secured to struts of the frame of the prosthetic heart valve, thereby securing the cusp edge portion of the leaflet to the frame, proximate to an inflow end of the frame. The connecting skirt can include side extension portions that extend outward from the cusp edge portion of the leaflet and across struts of the frame that are arranged between cusp edge portions of adjacent leaflets, when the connecting skirt is attached to struts of the frame. In this way, the side extension portions can cover inner surfaces of struts of the frame and/or apices of the frame at the inflow end of the frame.
Prosthetic valves disclosed herein can be radially compressible and expandable between a radially compressed configuration and a radially expanded configuration. Thus, the prosthetic valves can be crimped on or retained by an implant delivery apparatus in the radially compressed configuration during delivery, and then expanded to the radially expanded configuration once the prosthetic valve reaches the implantation site. It is understood that the prosthetic valves disclosed herein may be used with a variety of implant delivery apparatuses and can be implanted via various delivery procedures, examples of which will be discussed in more detail later. In some examples, the prosthetic valve can be deployed from the delivery apparatus at the implantation site (e.g., a native valve of a heart) via inflating an inflatable balloon of the delivery apparatus. When radially compressed onto the inflatable balloon of the delivery apparatus, inner surfaces of the frame of the prosthetic valve can face the balloon.
In some examples, the disclosed prosthetic valves can be implanted within a docking or anchoring device that is implanted within a native heart valve or a vessel. For example, in one example, the disclosed prosthetic valves can be implanted within a docking device implanted within the pulmonary artery for replacing the function of a diseased pulmonary valve, such as disclosed in U.S. Publication No. 2017/0231756, which is incorporated by reference herein. In another example, the disclosed prosthetic valves can be implanted within a docking device implanted within or at the native mitral valve, such as disclosed in PCT Publication No. WO2020/247907, which is incorporated herein by reference. In another example, the disclosed prosthetic valves can be implanted within a docking device implanted within the superior or inferior vena cava for replacing the function of a diseased tricuspid valve, such as disclosed in U.S. Publication No. 2019/0000615, which is incorporated herein by reference.
The prosthetic valve 150 can have three main components: a stent or frame, 152, a valvular structure 154, and a sealing member 156.
The valvular structure 154 can comprise three leaflets 160, collectively forming a leaflet structure, which can be arranged to collapse in a tricuspid arrangement, although in other examples there can be greater or fewer number of leaflets (e.g., one or more leaflets 160). In some examples, the leaflets 160 can be formed of pericardial tissue (e.g., bovine pericardial tissue), biocompatible synthetic materials, or various other suitable natural or synthetic materials as known in the art and described in U.S. Pat. No. 6,730,118, which is incorporated by reference herein.
Each leaflet 160 can be coupled to the frame 152 along its inflow edge 162 (the lower edge in the figures; also referred to as “cusp edges”) and at commissures 164 of the valvular structure 154 where adjacent portions (e.g., commissure tabs) of two leaflets are connected to each other. In some examples, the commissures 164 can comprise an attachment member (e.g., comprising fabric, flexible polymer, or the like) arranged across a cell (e.g., commissure cell) of the frame 152, the cell formed by struts of the frame. The attachment member can be secured to the struts of the frame forming the cell and the adjacent portions of the two leaflets can be connected to the attachment member to form the commissure 164 (e.g., as shown in
In some examples, a reinforcing element or connecting skirt, such as a fabric strip, can be connected directly to the cusp edges of the leaflets and to the struts of the frame to couple the cusp edges of the leaflets to the frame (e.g., as shown in
The frame 152 can be made of any of various suitable plastically-expandable materials (e.g., stainless steel, etc.) or self-expanding materials (e.g., nickel titanium alloy (NiTi), such as nitinol), as known in the art. When constructed of a plastically-expandable material, the frame 152 (and thus the prosthetic valve 150) can be crimped to a radially collapsed configuration on a delivery apparatus (e.g., catheter) and then expanded inside a patient by an inflatable balloon or equivalent expansion mechanism. When constructed of a self-expandable material, the frame 152 (and thus the prosthetic valve 150) can be crimped to a radially collapsed configuration and restrained in the collapsed configuration by insertion into a sheath or equivalent mechanism of a delivery apparatus. Once inside the body, the prosthetic valve can be advanced from the delivery sheath, which allows the prosthetic valve to expand to its functional size.
Suitable plastically-expandable materials that can be used to form the frame 152 include, without limitation, stainless steel, a biocompatible, high-strength alloys (e.g., a cobalt-chromium or a nickel-cobalt-chromium alloys), polymers, or combinations thereof. In particular examples, frame 152 is made of a nickel-cobalt-chromium-molybdenum alloy, such as MP35N® alloy (SPS Technologies, Jenkintown, Pennsylvania), which is equivalent to UNS R30035 alloy (covered by ASTM F562-02). MP35N® alloy/UNS R30035 alloy comprises 35% nickel, 35% cobalt, 20% chromium, and 10% molybdenum, by weight.
The frame 152 in the illustrated example comprises a plurality of circumferentially extending rows of angled struts 172 defining rows of open cells, or openings, 174 of the frame. The frame 152 can have a cylindrical or substantially cylindrical shape having a constant diameter from the inflow end 166 to the outflow end 168 of the frame 152 as shown, or the frame 152 can vary in diameter along the height of the frame, as disclosed in U.S. Patent Publication No. 2012/0239142, which is incorporated herein by reference.
The frame 152, at each of the inflow end 166 and the outflow end 168, may comprise a plurality of apices 180 spaced apart from one another around a circumference of the frame 152.
The sealing member 156 in the illustrated example is mounted on the outside of the frame 152 and functions to create a seal against the surrounding tissue (e.g., the native leaflets and/or native annulus) to prevent or at least minimize paravalvular leakage. The sealing member 156 can comprise an inner layer 176 (which can be in contact with the outer surface of the frame 152) and an outer layer 178. The sealing member 156 can be connected to the frame 152 using suitable techniques or mechanisms. For example, the sealing member 156 can be sutured to the frame 152 via sutures that can extend around the struts 172 and through the inner layer 176. In alternative examples, the inner layer 176 can be mounted on the inner surface of the frame 152, while the outer layer 178 is on the outside of the frame 152.
The outer layer 178 can be configured or shaped to extend radially outward from the inner layer 176 and the frame 152 when the prosthetic valve 150 is deployed. When the prosthetic valve is fully expanded outside of a patient's body, the outer layer 178 can expand away from the inner layer 176 to create a space between the two layers. Thus, when implanted inside the body, this allows the outer layer 178 to expand into contact with the surrounding tissue.
Additional details regarding the prosthetic valve 150 and its various components are described in U.S. Patent Publication No. 2018/0028310, which is incorporated herein by reference.
In
For example,
Similar to the frame 152 of the prosthetic valve 150, the frame 202 of the prosthetic heart valve 200 comprises a plurality of angled and interconnected struts 208. As shown in
As shown in
In some examples, as shown in
For example, as shown in
As shown in
The delivery apparatus 300 in the illustrated example of
The outer shaft 304 and the intermediate shaft 306 can be configured to translate (e.g., move) longitudinally, along a central longitudinal axis 320 of the delivery apparatus 300, relative to one another to facilitate delivery and positioning of a prosthetic valve at an implantation site in a patient's body.
The intermediate shaft 306 can include a proximal end portion 310 that extends proximally from a proximal end of the handle 302, to an adaptor 312 (
The adaptor 312 can include a first port 338 configured to receive a guidewire therethrough and a second port 340 configured to receive fluid (e.g., inflation fluid) from a fluid source. The second port 340 can be fluidly coupled to an inner lumen of the intermediate shaft 306.
The intermediate shaft 306 can further include a distal end portion 316 that extends distally beyond a distal end of the outer shaft 304 (
The balloon 318 can be coupled to the distal end portion 316 of the intermediate shaft 306. For example, in some examples, a proximal end portion of the balloon 318 can be coupled to and/or around a distal end of the intermediate shaft 306 (
The balloon 318 can comprise a distal end portion (or section) 332, a proximal end portion (or section) 333, and an intermediate portion (or section) 335, the intermediate portion 335 disposed between the distal end portion 332 and the proximal end portion 333 (
In some examples, a distal end of the distal end portion 332 of the balloon 318 can be coupled to a distal end of the delivery apparatus 300, such as to a nose cone 322 (as shown in
In some examples, rotation of the intermediate shaft 306 can result in rotation of the balloon 318 and the prosthetic valve mounted thereon for rotational positioning of the prosthetic valve relative to the native anatomy at the target implantation site.
The balloon shoulder assembly is configured to maintain the prosthetic heart valve or other medical device at a fixed position on the balloon 318 during delivery through the patient's vasculature. The balloon shoulder assembly can include a distal shoulder 326 (
The outer shaft 304 can include a distal tip portion 328 mounted on its distal end (
In some examples, the nose cone 322 can be disposed distal to and be coupled to the distal shoulder 326. In some examples, the nose cone 322 can be coupled to the distal end portion of the inner shaft 308.
In some examples, an annular space can be defined between an outer surface of the inner shaft 308 and an inner surface of the intermediate shaft 306. In some examples, the annular space can be referred to as an inner lumen of the intermediate shaft 306. In some examples, the annular space can be configured to receive fluid from a fluid source via the second port 340 of the adaptor 312 (e.g., the annular space is in fluid communication with the second port 340 of the adaptor 312). The annular space can be fluidly coupled to a fluid passageway formed between the outer surface of the distal end portion of the inner shaft 308 and an inner surface of the balloon 318. As such, fluid from the fluid source can flow to the balloon 318 to inflate the balloon 318 and radially expand and deploy the prosthetic valve (e.g., prosthetic valve 370 shown in
An inner lumen of the inner shaft 308 can be configured to receive a guidewire therethrough, for navigating the distal end portion 309 of the delivery apparatus 300 to the target implantation site. As introduced above, the first port 338 of the adaptor 312 can be coupled to the inner lumen and configured to receive the guidewire. For example, the distal end portion 309 of the delivery apparatus 300 can be advanced over the guidewire, to the target implantation site.
As shown in
The handle 302 can include one or more additional adjustment mechanisms. For example, in some examples, the handle 302 can include an adjustment mechanism 361 including an adjustment member, such as the illustrated rotatable knob 362. The adjustment mechanism 361 can be configured to adjust the axial position of the intermediate shaft 306 relative to the outer shaft 304. In some examples, the handle 302 can further include a locking mechanism, which can include a rotatable knob 379, the locking mechanism configured to retain (e.g., lock) the position of the intermediate shaft 306 relative to the handle 302 and allow for fine positioning of the prosthetic valve 370 at the implantation site.
As shown in
As shown in in
Thus, when crimped or radially compressed around the balloon 318, as shown in
The prosthetic heart valve 400 can be similar to the prosthetic valve 200 of
For example, the prosthetic heart valve 400 can comprise the frame 202 and the valvular structure 204 connected to the frame 202, as described above. The prosthetic heart valve 400 can have a central longitudinal axis 402 arranged through a center of an interior of the frame 202. The frame 202 of the prosthetic heart valve 400 is shown alone in
Each leaflet 216 can have a lower or cusp edge portion 416 (
As shown in
In alternate examples, the leaflets of the valvular structure 204 can be configured differently that those shown in
As shown in
The connecting skirts 410 include side portions 406 with extension portions 414 that cover the inner surface of the struts 208 (including apices 254) between adjacent leaflets 216, at the inflow end 210 of the frame 202 (
A single connecting skirt 410 of the prosthetic heart valve 400 is shown in
Each side portion 406 of the connecting skirt 410 can include a base portion 412 (also referred to as a side base portion) and an extension portion 414 (also referred to as a side extension portion) which extends outwardly from the base portion 412. In some examples, as shown in
For example, each extension portion 414 can include a first angled edge 460 that extends outward, at an angle, from and relative to a free end 461 of the base portion 412 of the corresponding side portion 406. Each extension portion 414 can further include a perpendicular edge 462 that extends outward from an end of the base portion 412 that is connected to the central portion 404 of the connecting skirt 410. The perpendicular edge 462 can be parallel to the free end 461 of the base portion 412 of the corresponding side portion 406. The extension portion 414 can further include a second angled edge 463 that extends outward (e.g., away from the base portion 412), at an angle, from and relative to the perpendicular edge 462. The first angled edge 460 and the second angled edge 463 can meet at a point 465 that is spaced outward and away from the base portion 412. Thus, extension portions 414 of the side portions 406 extend outward and past the central portion 404 of the connecting skirt 410.
In some examples, an angle 459 between the first angled edge 460 and the second angled edge 463 can be in a range of about 45 degrees to about 120 degrees, about 75 degrees to about 100 degrees, or about 85 degrees to about 95 degrees.
Thus, due to the shape of the side portions 406 of the connecting skirt 410, the connecting skirt 410 can have a relatively straight first edge 471 (e.g., bottom edge in
In some examples, together, the central portion 404 and the two base portions 412 can be referred to as a base portion of the connecting skirt and the two extension portions 414 can extend outwardly and away from the base portion.
The connecting skirt 410 can be formed with slits 408 partially separating the side portions 406 from the central portion 404 (
In alternative examples, plural connecting skirts can be provided for the cusp edge portion 416 of each leaflet 216 (e.g., the central portion 404 and the side portions 406 can be separate pieces of fabric). In another example, a single connecting skirt can be used to secure all of the leaflets 216 to the frame 202 (e.g., a single connecting skirt can be sized to extend along the cusp edge portions 416 of all of the leaflets 216 of the valvular structure 204).
In some examples, each connecting skirt 410 can include a plurality of apertures configured as suture holes that are configured to receive a stitch or suture for attaching the connecting skirt 410 to the leaflet 216 and/or the frame 202. For example, in some examples, the apertures can include a first row of apertures 484, a second row of apertures 486, a third row of apertures 488, and a fourth row of apertures 490 which each include a plurality of apertures spaced apart from one another along a length of the base portion 412 of each side portion 406 and the central portion 404 (
To attach a connecting skirt 410 to a corresponding leaflet 216, the base portions 412 of the side portions 406 and the central portion 404 can first be folded over on themselves (e.g. in half), as illustrated by the arrows 494 in
The folded base portions 412 and central portion 404 can then be arranged along the inner surface 480 of the cusp edge portion 416 of the leaflet 216 (
As shown in
The extension portions 414 of the side portions 406 of the connecting skirt 410 extend away from the cusp edge portion 416 and across a portion of the inner surface 480 of the leaflet 216. In some examples, as shown in
After placing the connecting skirt 410 on the inner surface 480 of the leaflet 216, as shown in
While
Together, the leaflet 216 and attached connecting skirt 410, as shown in
In some examples, a reinforcing member or chord 466 (e.g., an Ethibond suture) can be placed against the outer surface 482 of the cusp edge portion 416, opposite the connecting skirt 410 (
In some examples, when suturing the reinforcing chord 466 to the leaflet 216, the lower tabs 418 can be folded downwardly against the cusp edge portion 416 (see
In some examples, a single reinforcing chord 466 can extend continuously along the cusp edge portions 416 of all of the leaflets 216 of the valvular structure 204 and through the spaces beneath each commissure 498. In other examples, plural reinforcing chords 466 can be used, with one reinforcing chord secured to the cusp edge portion of each leaflet 216. Where multiple reinforcing chords 466 are used, the ends of each chord can be connected (e.g., by tying or knotting) to adjacent ends of the other chords. For example, adjacent ends of two chords can be connected to each in the space underneath a commissure.
After each connecting skirt 410 is secured to each respective leaflet 216, forming a leaflet assembly 485, the leaflet assemblies 485 (e.g., three shown in
As shown in
In some examples, one or more tails 425 of the one or more sutures 422 can be connected to struts 208 of the frame 202.
Once the leaflet assemblies 485 are secured together, the valvular structure 204 can be arranged within an interior of the frame 202 and secured to the frame 202, as shown in
To secure the cusp edge portions 416 of each leaflet 216 of the valvular structure 204 to the frame 202, the folded over central portion 404 and base portions 412 of each connecting skirt 410 can be secured (e.g., sutured) to struts 208 of the frame 202. In some examples, one or more sutures 470 (forming stitches) can extend through the folded over central portion 404 and base portions 412 of each connecting skirt 410 and around struts 208 of the frame 202, along a length of the cusp edge portions 416 to secure the cusp edge portions 416 of the leaflets 216 to the frame 202 (
For example,
In some examples, the one or more sutures 470 can extend through the folded over portions of the connecting skirt 410, around a strut 208 (as shown from the exterior view of
In some examples, the stitches formed by the one or more sutures 470 can comprise a plurality of whip stitches. In some examples, individual stitches 472 can secure each connecting skirt 410 to corresponding strut junctions 256 (
In some examples, the whip stitches of the one or more sutures 470 optionally can extend through the cusp edge portion 416 of the leaflets 216.
In some examples, attaching the connecting skirt 410 to the frame 202, as described above, can cause the cusp edge portion 416 of the leaflet 216 to fold over itself, toward the frame 202, as shown in
As a result of the folding over of the cusp edge portion 416 of the leaflet 216 as it is attached to the frame 202, the extension portions 414 can cover a second set or portion of struts 208 and apices 254 of the frame 202 that are arranged at the inflow end 210, between cusp edge portions 416 of adjacent leaflets 216 (
In some examples, portions of two adjacent extension portions 414 of two adjacent connecting skirts 410 overlap one another, thereby forming overlapping extension portions 476. As shown in
As shown in
Thus, when the prosthetic heart valve 400 is radially compressed around and onto an inflatable balloon of a delivery apparatus (e.g., balloon 318), as shown in
The valvular structure 204 can be further secured to the frame 202 by forming commissures 498 and mounting them to the frame 202, as shown in the exemplary method presented at
As shown in
Referring to
The commissure attachment member 431 can be folded as shown in
The outer layers 442 can be secured to the frame 12, such as by suturing the outer peripheral edges 432 to struts 208 with stitching 448 (
Additional details regarding the method for forming commissures 498 and securing them to the frame 202 of the prosthetic heart valve are described in U.S. Patent Publication No. 2018/0028310, which is incorporated herein by reference.
In some examples, after securing the valvular structure 204 to the frame 202, as described above, an outer sealing member 454 can be mounted around an outer surface 456 of the frame 202 (
In this way, leaflets of a valvular structure can be attached to a frame of a prosthetic heart valve using one or more connecting skirts. For example, a central portion and side base portions of a connecting skirt can be secured directly to a cusp edge portion of a corresponding leaflet and the central portion and side base portions of the connecting skirt can be secured directly to struts of the frame, thereby securing the attached leaflet to the frame. Each connecting skirt can further include side extension portions that extend across struts of the frame that are disposed between cusp edge portions of adjacent leaflets (e.g., when the valvular structure is attached to the frame, as described above). As a result, the side extension portions of the connecting skirts can cover inner surfaces of the struts and apices at the inflow end of the frame that are otherwise uncovered by the leaflets. Thus, when the prosthetic heart valve is radially compressed onto and around an inflatable balloon of a delivery apparatus, the extension portions of the connecting skirts can serve as a protective barrier between the balloon and apices and struts of the frame. As a result, a longevity and effectiveness (e.g., ability to inflate) of the balloon can be increased.
Delivery Techniques
For implanting a prosthetic valve within the native aortic valve via a transfemoral delivery approach, the prosthetic valve is mounted in a radially compressed state along the distal end portion of a delivery apparatus. The prosthetic valve and the distal end potion of the delivery apparatus are inserted into a femoral artery and are advanced into and through the descending aorta, around the aortic arch, and through the ascending aorta. The prosthetic valve is positioned within the native aortic valve and radially expanded (e.g., by inflating a balloon, actuating one or more actuators of the delivery apparatus, or deploying the prosthetic valve from a sheath to allow the prosthetic valve to self-expand). Alternatively, a prosthetic valve can be implanted within the native aortic valve in a transapical procedure, whereby the prosthetic valve (on the distal end portion of the delivery apparatus) is introduced into the left ventricle through a surgical opening in the chest and the apex of the heart and the prosthetic valve is positioned within the native aortic valve. Alternatively, in a transaortic procedure, a prosthetic valve (on the distal end portion of the delivery apparatus) are introduced into the aorta through a surgical incision in the ascending aorta, such as through a partial J-sternotomy or right parasternal mini-thoracotomy, and then advanced through the ascending aorta toward the native aortic valve.
For implanting a prosthetic valve within the native mitral valve via a transseptal delivery approach, the prosthetic valve is mounted in a radially compressed state along the distal end portion of a delivery apparatus. The prosthetic valve and the distal end portion of the delivery apparatus are inserted into a femoral vein and are advanced into and through the inferior vena cava, into the right atrium, across the atrial septum (through a puncture made in the atrial septum), into the left atrium, and toward the native mitral valve. Alternatively, a prosthetic valve can be implanted within the native mitral valve in a transapical procedure, whereby the prosthetic valve (on the distal end portion of the delivery apparatus) is introduced into the left ventricle through a surgical opening in the chest and the apex of the heart and the prosthetic valve is positioned within the native mitral valve.
For implanting a prosthetic valve within the native tricuspid valve, the prosthetic valve is mounted in a radially compressed state along the distal end portion of a delivery apparatus. The prosthetic valve and the distal end portion of the delivery apparatus are inserted into a femoral vein and are advanced into and through the inferior vena cava, and into the right atrium, and the prosthetic valve is positioned within the native tricuspid valve. A similar approach can be used for implanting the prosthetic valve within the native pulmonary valve or the pulmonary artery, except that the prosthetic valve is advanced through the native tricuspid valve into the right ventricle and toward the pulmonary valve/pulmonary artery.
Another delivery approach is a transatrial approach whereby a prosthetic valve (on the distal end portion of the delivery apparatus) is inserted through an incision in the chest and an incision made through an atrial wall (of the right or left atrium) for accessing any of the native heart valves. Atrial delivery can also be made intravascularly, such as from a pulmonary vein. Still another delivery approach is a transventricular approach whereby a prosthetic valve (on the distal end portion of the delivery apparatus) is inserted through an incision in the chest and an incision made through the wall of the right ventricle (typically at or near the base of the heart) for implanting the prosthetic valve within the native tricuspid valve, the native pulmonary valve, or the pulmonary artery.
In all delivery approaches, the delivery apparatus can be advanced over a guidewire previously inserted into a patient's vasculature. Moreover, the disclosed delivery approaches are not intended to be limited. Any of the prosthetic valves disclosed herein can be implanted using any of various delivery procedures and delivery devices known in the art.
In view of the above described implementations of the disclosed subject matter, this application discloses the additional examples enumerated below. It should be noted that one feature of an example in isolation or more than one feature of the example taken in combination and, optionally, in combination with one or more features of one or more further examples are further examples also falling within the disclosure of this application.
Example 1. A prosthetic heart valve comprising: an annular frame comprising an inflow end and an outflow end and being radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration, wherein the frame comprises a plurality of struts; and a valvular structure mounted within the frame and comprising a plurality of leaflets, wherein each leaflet comprises opposing tabs on opposite sides of the leaflet and a cusp edge portion between the tabs; wherein the cusp edge portion of each leaflet is connected to the frame by a connecting skirt, wherein each connecting skirt comprises a central portion and opposing side base portions on opposite sides of the central portion that are connected to each of and disposed between the frame and the cusp edge portion of the leaflet, and wherein each connecting skirt further comprises side extension portions that extend outward from the cusp edge portion of the leaflet and across struts of the frame that are disposed between cusp edge portions of adjacent leaflets.
Example 2. The prosthetic heart valve of any example herein, particularly example 1, wherein the plurality of struts form a plurality of apices at the inflow end and the outflow end of the frame and wherein each side extension portion of each connecting skirt extends across the struts of the frame that are disposed between cusp edge portion of adjacent leaflets such that an inner surface of each apex of the plurality of apices that are disposed at the inflow end of the frame, between adjacent leaflets, is covered by a corresponding side extension portion of a corresponding connecting skirt.
Example 3. The prosthetic heart valve of any example herein, particularly example 1 or example 2, wherein each side extension portion extends across one or more cells of a plurality of open cells defined by the plurality of struts, the one or more cells uncovered by the plurality of leaflets.
Example 4. The prosthetic heart valve of any example herein, particularly any one of examples 1-3, wherein each side extension portion is secured to an adjacent side extension portion of an adjacent connecting skirt.
Example 5. The prosthetic heart valve of any example herein, particularly example 4, wherein each side extension portion includes one or more apertures disposed in an angled edge of the side extension portion and wherein each side extension portion is secured to the adjacent side extension portion of the adjacent connecting skirt via one or more sutures extending through the one or more apertures.
Example 6. The prosthetic heart valve of any example herein, particularly any one of examples 1-5, wherein each connecting skirt includes one or more notches disposed between the central portion and the side base portions that are configured to allow the side base portions to bend relative to the central portion.
Example 7. The prosthetic heart valve of any example herein, particularly any one of examples 1-6, wherein each side extension portion of each connecting skirt is triangular and formed by two angled edges that extend outward from opposite ends of a respective side base portion of the side base portions of the connecting skirt.
Example 8. The prosthetic heart valve of any example herein, particularly any one of examples 1-7, wherein each connecting skirt includes a plurality of rows of apertures disposed in and extending across the side base portions and the central portion.
Example 9. The prosthetic heart valve of any example herein, particularly example 8, wherein, for each leaflet, the central portion and side base portions of the connecting skirt are arranged along and secured to the cusp edge portion of the leaflet via one or more sutures extending through a first two rows of the plurality of rows of apertures.
Example 10. The prosthetic heart valve of any example herein, particularly example 9, wherein, for each leaflet, the central portion and side base portions of the connecting skirt secured to the leaflet are further secured to struts of the plurality of struts of the frame via one or more sutures extending through a second two rows of the plurality of rows of apertures.
Example 11. The prosthetic heart valve of any example herein, particularly example 10, wherein the central portion and the side base portions are folded over lengthwise along the cusp edge portion of the leaflet to form two folded portions such that the first two rows overlap one another and the second two rows overlap one another.
Example 12. The prosthetic heart valve of any example herein, particularly any one of examples 1-11, wherein each leaflet and each connecting skirt are secured to each adjacent leaflet and each adjacent connecting skirt, along cusp edge portions of the plurality of leaflets, to form the valvular structure.
Example 13. The prosthetic heart valve of any example herein, particularly any one of examples 1-12, wherein each tab of the opposing tabs of each leaflet is paired with an adjacent tab of an adjacent leaflet to form a plurality of commissures that are connected to the frame, at the outflow end of the frame.
Example 14. The prosthetic heart valve of any example herein, particularly example 13, wherein each side extension portion covers an inner surface of struts of the frame that are disposed between struts of the frame that are connected to a commissure of the plurality of commissures and the inflow end of the frame.
Example 15. The prosthetic heart valve of any example herein, particularly any one of examples 1-14, further comprising an outer sealing member mounted on an outer surface of the frame and secured to each connecting skirt.
Example 16. The prosthetic heart valve of any example herein, particularly example 15, wherein the outer sealing member extends from the inflow end of the frame, toward the outflow end of the frame.
Example 17. A prosthetic heart valve comprising: an annular frame comprising an inflow end and an outflow end and being radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration, wherein the frame comprises a plurality of struts; a valvular structure mounted within the frame and comprising a plurality of leaflets, wherein each leaflet comprises opposing tabs on opposite sides of the leaflet and a cusp edge portion between the tabs, wherein each tab is paired with an adjacent tab of an adjacent leaflet to form a plurality of commissures that are connected to the frame; and a plurality of connecting skirts, each connecting skirt comprising side base portions and a central portion connected to each of the cusp edge portion of a corresponding leaflet of the plurality of leaflets and struts of the frame, each connecting skirt further comprising side extension portions that extend outward and away from the cusp edge portion, wherein each side extension portion of each connecting skirt extends across struts of the frame, between cusp edge portions of adjacent leaflets and connects to an adjacent side extension portion of an adjacent connecting skirt.
Example 18. The prosthetic heart valve of any example herein, particularly example 17, wherein each side extension portion connects to the adjacent side extension portion of the adjacent connecting skirt from a strut junction to which a corresponding commissure of the plurality of commissures is connected, to the inflow end of the frame.
Example 19. The prosthetic heart valve of any example herein, particularly example 17 or example 18, wherein each side extension portion extends from the cusp edge portion of a corresponding leaflet to the inflow end of the frame and covers an inner surface of an apex of the frame at the inflow end.
Example 20. The prosthetic heart valve of any example herein, particularly any one of examples 17-19, wherein each connecting skirt includes two side base portions, each arranged on an opposite side of the central portion, and two side extension portions, each side extension portion extending outward from a corresponding side base portion of the two side base portions.
Example 21. The prosthetic heart valve of any example herein, particularly example 20, wherein each side extension portion is triangular.
Example 22. The prosthetic heart valve of any example herein, particularly example 20 or example 21, wherein the two side base portions and central portion of each connecting skirt are rectangular.
Example 23. The prosthetic heart valve of any example herein, particularly any one of examples 20-22, wherein for each connecting skirt, the two side base portions and the central portion form a straight, first edge of the connecting skirt and wherein the two side extension portions form a non-straight, second edge arranged opposite the first edge, the non-straight second edge having multiple angled edges.
Example 24. The prosthetic heart valve of any example herein, particularly any one of examples 20-23, wherein each side extension portion of each connecting skirt includes an angled edge extending from a free end of the corresponding side base portion and wherein each side extension portion includes one or more apertures disposed therein, adjacent to the angled edge.
Example 25. The prosthetic heart valve of any example herein, particularly example 24, wherein each side extension portion at least partially overlaps and is connected to the adjacent side extension portion of the adjacent connecting skirt by one or more sutures extending through the one or more apertures in each of the side extension portion and the adjacent side extension portion.
Example 26. The prosthetic heart valve of any example herein, particularly any one of examples 20-25, wherein each connecting skirt includes a plurality of rows of apertures in the central portion and two side base portions and wherein each row of apertures includes a plurality of apertures spaced apart from one another and extending from a free end of one side base portion of the two side base portions to another side base portion of the two side base portions.
Example 27. The prosthetic heart valve of any example herein, particularly example 26, wherein the plurality of rows of apertures includes four rows of apertures that are spaced apart from one another and wherein the central portion and the two side base portions are folded lengthwise and arranged along the cusp edge portion of the corresponding leaflet such that two fold layers are formed and a first and fourth row of apertures of the four rows of apertures overlap one another and a second and third row of apertures of the four rows of apertures overlap one another.
Example 28. The prosthetic heart valve of any example herein, particularly example 27, wherein each connecting skirt is secured to the cusp edge portion of the corresponding leaflet via one or more sutures that extend through the second and third row of apertures.
Example 29. The prosthetic heart valve of any example herein, particularly example 28, wherein each connecting skirt is secured to the struts of the frame via one or more sutures that extend through the first and fourth row of apertures.
Example 30. The prosthetic heart valve of any example herein, particularly any one of examples 20-29, wherein each connecting skirt includes slits that partially separate the two side base portions from the central portion to allow the connecting skirt to be aligned along the cusp edge portion of the corresponding leaflet.
Example 31. The prosthetic heart valve of any example herein, particularly example 30, wherein the cusp edge portion of each leaflet includes a central portion and two angled side edge portions that extend from either side of the central portion to a respective one of the opposing tabs.
Example 32. The prosthetic heart valve of any example herein, particularly any one of examples 17-31, wherein the plurality of struts form a plurality of open cells and wherein each commissure of the plurality of commissures is disposed across a cell of the plurality of open cells that is disposed at the outflow end of the frame.
Example 33. The prosthetic heart valve of any example herein, particularly example 32, wherein the side extension portions of adjacent connecting skirts extend across cells of the plurality of open cells that are disposed between the cell including the commissure and the inflow end of the frame.
Example 34. The prosthetic heart valve of any example herein, particularly any one of examples 17-33, further comprising an outer sealing member mounted around an outer surface of the frame and secured to the struts of the frame and the plurality of connecting skirts, the plurality of connecting skirts mounted around an inner surface of the frame.
Example 35. A method of assembling a prosthetic heart valve comprising a plurality of leaflets, the method comprising: forming a plurality of leaflet assemblies with the plurality of leaflets, wherein each leaflet assembly is formed by: securing a central portion and side base portions of a connecting skirt to a cusp edge portion of a leaflet, wherein each connecting skirt comprises two side portions, one arranged on either side of the central portion, and wherein each side portion comprises a corresponding side base portion of the side base portions and a side extension portion extending outward and away from the corresponding side base portion; securing each connecting skirt to a frame of the prosthetic heart valve, the frame comprising a plurality of interconnected and angled struts, the securing including: securing the central portion and side base portions of the connecting skirt to a first portion of struts of the plurality of struts; and extending each side extension portion of the connecting skirt across a second portion of struts of the plurality of struts that are disposed between cusp edge portions of adjacent leaflets and securing each side extension portion to an adjacent side extension portion of an adjacent connecting skirt.
Example 36. The method of any example herein, particularly example 35, wherein securing the central portion and side base portion of the connecting skirt to the cusp edge portion of the leaflet includes folding the central portion and side base portion lengthwise to form two fold layers and securing the two fold layers to the cusp edge portion of the leaflet.
Example 37. The method of any example herein, particularly example 36, wherein each connecting skirt includes a plurality of rows of apertures extending along the central portion and side base portions and wherein securing the two fold layers to the cusp edge portion of the leaflet includes extending one or more sutures through the cusp edge portion of the leaflet and overlapping apertures of a first two rows of apertures of the plurality of rows of apertures, along a length of the cusp edge portion, to secure the central portion and the side base portions of the connecting skirt to the cusp edge portion of the leaflet.
Example 38. The method of any example herein, particularly example 36 or example 37, wherein during the securing the central portion and side base portions of the connecting skirt to the cusp edge portion of the leaflet, each side extension portion of the connecting skirt extends outward from the two fold layers and across an inner surface of the leaflet.
Example 39. The method of any example herein, particularly any one of examples 36-38, wherein securing the central portion and side base portions of the connecting skirt to the first portion of struts includes securing the two fold layers of the connecting skirt to the first portion of struts via one or more sutures extending through overlapping apertures of a second two rows of apertures of the plurality of rows of apertures and around the first portion of struts, along a length of the cusp edge portion of the leaflet
Example 40. The method of any example herein, particularly any one of examples 35-39, wherein extending each side extension portion of the connecting skirt across the second portion of struts includes covering inner surfaces of the second portion of struts and an apex of the frame that is arranged at an inflow end of the frame with the side extension portion.
Example 41. The method of any example herein, particularly any one of examples 35-39, wherein securing each side extension portion to the adjacent side extension portion of the adjacent connecting skirt includes securing overlapping portions of the side extension portion and the adjacent side extension portion together via one or more sutures.
Example 42. The method of any example herein, particularly example 41, wherein securing the overlapping portions together includes extending one or more sutures through the overlapping portions, from a strut junction where the cusp edge portions of the adjacent leaflets meet to an inflow end of the frame.
Example 43. The method of any example herein, particularly any one of examples 35-42, further comprising, after forming the plurality of leaflet assemblies, connecting the plurality of leaflet assemblies together to form a valvular structure, arranging the valvular structure within an interior of the frame, and then securing each connecting skirt to the frame.
Example 44. The method of any example herein, particularly example 43, wherein connecting the plurality of leaflet assemblies together to form the valvular structure includes extending one or more sutures through each connecting skirt and cusp edge portion of each leaflet to form a stitching line along and between each cusp edge portion of each leaflet of the valvular structure.
Example 45. The method of any example herein, particularly any one of examples 35-44, wherein each leaflet comprises opposing tabs on opposite sides of the cusp edge portion of the leaflet and further comprising pairing each tab with an adjacent tab of an adjacent leaflet to form a commissure and securing the commissure to the frame.
Example 46. The method of any example herein, particularly example 45, wherein securing the commissure to the frame includes securing the commissure to a third portion of struts of the plurality of struts that form a cell at an outflow end of the frame.
Example 47. The method of any example herein, particularly example 45 or example 46, wherein the first portion of struts are struts extending at an angle from a first commissure to an inflow end of the frame and at an angle from the inflow end to a second commissure.
Example 48. The method of any example herein, particularly any one of examples 45-47, wherein securing each side extension portion to the adjacent side extension portion of the adjacent connecting skirt includes securing each side extension portion to the adjacent side extension portion via extending one or more sutures through overlapping portions of the side extension portion and the adjacent side extension portion which extend from the commissure to an inflow end of the frame.
Example 49. The method of any example herein, particularly any one of examples 35-48, further comprising mounting an outer sealing member around an outer surface of the frame and securing the outer sealing member to struts of the frame and each connecting skirt.
Example 50. A prosthetic heart valve comprising: an annular frame comprising an inflow end and an outflow end and being radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration, wherein the frame comprises a plurality of struts; a valvular structure mounted within the frame and comprising a plurality of leaflets, wherein each leaflet comprises opposing tabs on opposite sides of the leaflet and a cusp edge portion between the tabs, wherein each tab is paired with an adjacent tab of an adjacent leaflet to form a plurality of commissures that are connected to the frame; a plurality of connecting skirts, each connecting skirt comprising a base portion connected to each of the cusp edge portion of a corresponding leaflet of the plurality of leaflets and struts of the frame, each connecting skirt further comprising extension portions that extend outward and away from the cusp edge portion and cover inner surfaces of struts of the frame disposed between cusp edge portions of adjacent leaflets; and an outer sealing member mounted around an outer surface of the frame and secured to the struts of the frame and the plurality of connecting skirts, the plurality of connecting skirts mounted around an inner surface of the frame.
Example 51. The prosthetic heart valve of any example herein, particularly example 50, wherein a portion of the struts of the frame covered by the extension portions of each leaflet form apices at the inflow end of the frame.
Example 52. The prosthetic heart valve of any example herein, particularly any one of examples 50 or example 51, wherein the base portion of each connecting skirt comprises a central portion and opposing side base portions disposed on either side of the central portion and wherein each extension portion of the connecting skirt extends outward from a respective side base portion of the opposing side base portions.
Example 53. The prosthetic heart valve of any example herein, particularly any one of examples 50-52, wherein the extension portions are triangular.
Example 54. The prosthetic heart valve of any example herein, particularly any one of examples 50-53, wherein each extension portion of each connecting skirt is attached to an adjacent extension portion of an adjacent connecting skirt.
Example 55. The prosthetic heart valve of any example herein, particularly example 54, wherein each extension portion is attached to the adjacent extension portion in a region of the frame that is disposed between, in an axial direction that is relative to a central longitudinal axis of the frame, a commissure of the plurality of commissures and the inflow end of the frame.
In view of the many possible examples to which the principles of the disclosed technology may be applied, it should be recognized that the illustrated examples are only examples of the disclosed technology and should not be taken as limiting the scope of the claimed subject matter. Rather, the scope of the claimed subject matter is defined by the following claims and their equivalents.
This application is a continuation of PCT Application No. PCT/US2022/012873, filed Jan. 19, 2022, which claims the benefit of U.S. Provisional Patent Application No. 63/139,514, filed Jan. 20, 2021, both of which applications are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3409013 | Berry | Nov 1968 | A |
3548417 | Kisher | Dec 1970 | A |
3587115 | Shiley | Jun 1971 | A |
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3714671 | Edwards et al. | Feb 1973 | A |
3755823 | Hancock | Sep 1973 | A |
4035849 | Angell et al. | Jul 1977 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos et al. | May 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
RE30912 | Hancock | Apr 1982 | E |
4339831 | Johnson | Jul 1982 | A |
4343048 | Ross et al. | Aug 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4373216 | Klawitter | Feb 1983 | A |
4406022 | Roy | Sep 1983 | A |
4441216 | Ionescu et al. | Apr 1984 | A |
4470157 | Love | Sep 1984 | A |
4535483 | Klawitter et al. | Aug 1985 | A |
4574803 | Storz | Mar 1986 | A |
4592340 | Boyles | Jun 1986 | A |
4605407 | Black et al. | Aug 1986 | A |
4612011 | Kautzky | Sep 1986 | A |
4643732 | Pietsch et al. | Feb 1987 | A |
4655771 | Wallsten | Apr 1987 | A |
4692164 | Dzemeshkevich et al. | Sep 1987 | A |
4733665 | Palmaz | Mar 1988 | A |
4759758 | Gabbay | Jul 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4787901 | Baykut | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4820299 | Philippe et al. | Apr 1989 | A |
4829990 | Thuroff et al. | May 1989 | A |
4851001 | Taheri | Jul 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4883458 | Shiber | Nov 1989 | A |
4922905 | Strecker | May 1990 | A |
4966604 | Reiss | Oct 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4986830 | Owens et al. | Jan 1991 | A |
4994077 | Dobben | Feb 1991 | A |
5007896 | Shiber | Apr 1991 | A |
5026366 | Leckrone | Jun 1991 | A |
5032128 | Alonso | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5047041 | Samuels | Sep 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5080668 | Bolz et al. | Jan 1992 | A |
5085635 | Cragg | Feb 1992 | A |
5089015 | Ross | Feb 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5163953 | Vince | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5192297 | Hull | Mar 1993 | A |
5266073 | Wall | Nov 1993 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5295958 | Shturman | Mar 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5360444 | Kusuhara | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5411055 | Kane | May 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5480424 | Cox | Jan 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5558644 | Boyd et al. | Sep 1996 | A |
5571175 | Vanney et al. | Nov 1996 | A |
5584803 | Stevens et al. | Dec 1996 | A |
5591185 | Kilmer et al. | Jan 1997 | A |
5591195 | Taheri et al. | Jan 1997 | A |
5607464 | Trescony et al. | Mar 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5628792 | Lentell | May 1997 | A |
5639274 | Fischell et al. | Jun 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5716417 | Girard et al. | Feb 1998 | A |
5728068 | Leone et al. | Mar 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5756476 | Epstein et al. | May 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5855602 | Angell | Jan 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
6027525 | Suh et al. | Feb 2000 | A |
6132473 | Williams et al. | Oct 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6174327 | Mertens et al. | Jan 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6217585 | Houser et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6231602 | Carpentier et al. | May 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6299637 | Shaolian et al. | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6338740 | Carpentier | Jan 2002 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6352547 | Brown et al. | Mar 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440764 | Focht et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6468660 | Ogle et al. | Oct 2002 | B2 |
6482228 | Norred | Nov 2002 | B1 |
6488704 | Connelly et al. | Dec 2002 | B1 |
6527979 | Constantz et al. | Mar 2003 | B2 |
6569196 | Vesely | May 2003 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6605112 | Moll et al. | Aug 2003 | B1 |
6652578 | Balley et al. | Nov 2003 | B2 |
6689123 | Pinchasik | Feb 2004 | B2 |
6716244 | Klaco | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6767362 | Schreck | Jul 2004 | B2 |
6769161 | Brown et al. | Aug 2004 | B2 |
6783542 | Eldenschink | Aug 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6878162 | Bales et al. | Apr 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6936067 | Buchanan | Aug 2005 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7018408 | Bailey et al. | Mar 2006 | B2 |
7096554 | Austin et al. | Aug 2006 | B2 |
7225518 | Eldenschink et al. | Jun 2007 | B2 |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7316710 | Cheng et al. | Jan 2008 | B1 |
7318278 | Zhang et al. | Jan 2008 | B2 |
7374571 | Pease et al. | May 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7563280 | Anderson et al. | Jul 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7618447 | Case et al. | Nov 2009 | B2 |
7655034 | Mitchell et al. | Feb 2010 | B2 |
7785366 | Maurer et al. | Aug 2010 | B2 |
7959665 | Pienknagura | Jun 2011 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
8029556 | Rowe | Oct 2011 | B2 |
8075611 | Millwee et al. | Dec 2011 | B2 |
8128686 | Paul, Jr. et al. | Mar 2012 | B2 |
8167932 | Bourang et al. | May 2012 | B2 |
8291570 | Eidenschink et al. | Oct 2012 | B2 |
8348998 | Pintor et al. | Jan 2013 | B2 |
8449606 | Ellasen et al. | May 2013 | B2 |
8454685 | Hariton et al. | Jun 2013 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8685055 | VanTassel et al. | Apr 2014 | B2 |
8747463 | Fogarty et al. | Jun 2014 | B2 |
9078781 | Ryan et al. | Jul 2015 | B2 |
11096781 | Gurovich | Aug 2021 | B2 |
11224509 | Dasi et al. | Jan 2022 | B2 |
20010021872 | Balley et al. | Sep 2001 | A1 |
20020026094 | Roth | Feb 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020138135 | Duerig et al. | Sep 2002 | A1 |
20020143390 | Ishil | Oct 2002 | A1 |
20020173842 | Buchanan | Nov 2002 | A1 |
20030014105 | Cao | Jan 2003 | A1 |
20030040791 | Oktay | Feb 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030100939 | Yodfat et al. | May 2003 | A1 |
20030158597 | Quiachon et al. | Aug 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20040024452 | Kruse et al. | Feb 2004 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040078074 | Anderson et al. | Apr 2004 | A1 |
20040186558 | Pavcnik et al. | Sep 2004 | A1 |
20040186563 | Lobbi | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20050010285 | Lambrecht et al. | Jan 2005 | A1 |
20050075725 | Rowe | Apr 2005 | A1 |
20050075728 | Nguyen et al. | Apr 2005 | A1 |
20050096736 | Osse et al. | May 2005 | A1 |
20050096738 | Call et al. | May 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050188525 | Weber et al. | Sep 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20060004469 | Sokel | Jan 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060108090 | Ederer et al. | May 2006 | A1 |
20060149350 | Patel et al. | Jul 2006 | A1 |
20060183383 | Asmus et al. | Aug 2006 | A1 |
20060229719 | Marquez et al. | Oct 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060287717 | Rowe et al. | Dec 2006 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070162102 | Ryan et al. | Jul 2007 | A1 |
20070203503 | Salahieh et al. | Aug 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070203576 | Lee et al. | Aug 2007 | A1 |
20070208550 | Cao et al. | Sep 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070233228 | Eberhardt et al. | Oct 2007 | A1 |
20070260305 | Drews et al. | Nov 2007 | A1 |
20070265700 | Eliasen et al. | Nov 2007 | A1 |
20080021546 | Patz et al. | Jan 2008 | A1 |
20080114442 | Mitchell et al. | May 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080183271 | Frawley et al. | Jul 2008 | A1 |
20080208327 | Rowe | Aug 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080255660 | Guyenot et al. | Oct 2008 | A1 |
20080275537 | Limon | Nov 2008 | A1 |
20080294248 | Yang et al. | Nov 2008 | A1 |
20090118826 | Khaghani | May 2009 | A1 |
20090125118 | Gong | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287296 | Manasse | Nov 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090299452 | Eidenschink et al. | Dec 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20100004735 | Yang et al. | Jan 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100100176 | Elizondo et al. | Apr 2010 | A1 |
20100168844 | Toomes et al. | Jul 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100198347 | Zakay et al. | Aug 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20110015729 | Jimenez et al. | Jan 2011 | A1 |
20110022157 | Essinger et al. | Jan 2011 | A1 |
20110066224 | White | Mar 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110218619 | Benichou et al. | Sep 2011 | A1 |
20110319991 | Hariton et al. | Dec 2011 | A1 |
20120030090 | Johnston et al. | Feb 2012 | A1 |
20120089223 | Nguyen et al. | Apr 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120259409 | Nguyen et al. | Oct 2012 | A1 |
20130023985 | Khairkhahan et al. | Jan 2013 | A1 |
20130046373 | Cartledge et al. | Feb 2013 | A1 |
20130150956 | Yohanan et al. | Jun 2013 | A1 |
20130166017 | Cartledge et al. | Jun 2013 | A1 |
20130190857 | Mitra et al. | Jul 2013 | A1 |
20130274873 | Delaloye et al. | Oct 2013 | A1 |
20130310926 | Hariton | Nov 2013 | A1 |
20130317598 | Rowe et al. | Nov 2013 | A1 |
20130331929 | Mitra et al. | Dec 2013 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140200661 | Pintor et al. | Jul 2014 | A1 |
20140209238 | Bonyuet et al. | Jul 2014 | A1 |
20140222136 | Geist et al. | Aug 2014 | A1 |
20140277417 | Schraut et al. | Sep 2014 | A1 |
20140277419 | Garde et al. | Sep 2014 | A1 |
20140277424 | Oslund | Sep 2014 | A1 |
20140277563 | White | Sep 2014 | A1 |
20140296962 | Cartledge et al. | Oct 2014 | A1 |
20140330372 | Weston et al. | Nov 2014 | A1 |
20140343670 | Bakis et al. | Nov 2014 | A1 |
20140343671 | Yohanan et al. | Nov 2014 | A1 |
20140350667 | Braido et al. | Nov 2014 | A1 |
20150073545 | Braido | Mar 2015 | A1 |
20150073546 | Braido | Mar 2015 | A1 |
20150135506 | White | May 2015 | A1 |
20150157455 | Hoang et al. | Jun 2015 | A1 |
20160374802 | Levi et al. | Dec 2016 | A1 |
20170014229 | Nguyen-Thien-Nhon et al. | Jan 2017 | A1 |
20180028310 | Gurovich et al. | Feb 2018 | A1 |
20180153689 | Maimon et al. | Jun 2018 | A1 |
20180325665 | Gurovich et al. | Nov 2018 | A1 |
20180344456 | Barash et al. | Dec 2018 | A1 |
20190159894 | Levi et al. | May 2019 | A1 |
20190192288 | Levi et al. | Jun 2019 | A1 |
20190192289 | Levi et al. | Jun 2019 | A1 |
Number | Date | Country |
---|---|---|
0144167 | Sep 1903 | DE |
2246526 | Mar 1973 | DE |
19532846 | Mar 1997 | DE |
19546692 | Jun 1997 | DE |
19857887 | Jul 2000 | DE |
19907646 | Aug 2000 | DE |
10049812 | Apr 2002 | DE |
10049813 | Apr 2002 | DE |
10049814 | Apr 2002 | DE |
10049815 | Apr 2002 | DE |
0103546 | Mar 1984 | EP |
0850607 | Jul 1998 | EP |
1057460 | Dec 2000 | EP |
1088529 | Apr 2001 | EP |
1570809 | Sep 2005 | EP |
2788217 | Jul 2000 | FR |
2815844 | May 2002 | FR |
2056023 | Mar 1981 | GB |
1271508 | Nov 1986 | SU |
9117720 | Nov 1991 | WO |
9217118 | Oct 1992 | WO |
9301768 | Feb 1993 | WO |
9724080 | Jul 1997 | WO |
9829057 | Jul 1998 | WO |
9930646 | Jun 1999 | WO |
9933414 | Jul 1999 | WO |
9940964 | Aug 1999 | WO |
9947075 | Sep 1999 | WO |
0018333 | Apr 2000 | WO |
0041652 | Jul 2000 | WO |
0135878 | May 2001 | WO |
0149213 | Jul 2001 | WO |
0154624 | Aug 2001 | WO |
0154625 | Aug 2001 | WO |
0162189 | Aug 2001 | WO |
0047139 | Sep 2001 | WO |
0164137 | Sep 2001 | WO |
0176510 | Oct 2001 | WO |
0222054 | Mar 2002 | WO |
0236048 | May 2002 | WO |
0241789 | May 2002 | WO |
0243620 | Jun 2002 | WO |
0247575 | Jun 2002 | WO |
0249540 | Jun 2002 | WO |
03047468 | Jun 2003 | WO |
2005034812 | Apr 2005 | WO |
2005055883 | Jun 2005 | WO |
2005084595 | Sep 2005 | WO |
2005102015 | Nov 2005 | WO |
2006014233 | Feb 2006 | WO |
2006032051 | Mar 2006 | WO |
2006034008 | Mar 2006 | WO |
2006111391 | Oct 2006 | WO |
2006127089 | Nov 2006 | WO |
2006138173 | Dec 2006 | WO |
2007047488 | Apr 2007 | WO |
2007067942 | Jun 2007 | WO |
2007097983 | Aug 2007 | WO |
2008005405 | Jan 2008 | WO |
2008015257 | Feb 2008 | WO |
2008035337 | Mar 2008 | WO |
2008091515 | Jul 2008 | WO |
2008147964 | Dec 2008 | WO |
2008150529 | Dec 2008 | WO |
2009033469 | Mar 2009 | WO |
2009042196 | Apr 2009 | WO |
2009053497 | Apr 2009 | WO |
2009061389 | May 2009 | WO |
2009094188 | Jul 2009 | WO |
2009116041 | Sep 2009 | WO |
2009149462 | Dec 2009 | WO |
2010011699 | Jan 2010 | WO |
2010121076 | Oct 2010 | WO |
2013106585 | Jul 2013 | WO |
2015085218 | Jun 2015 | WO |
Entry |
---|
Al-Khaja, et al. “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery, vol. 3. pp. 305-311. 1989. |
Bailey, S. “Percutaneous Expandable Prosthetic Valves,” Textbook of Interventional Cardiology vol. 2, 2nd Ed. pp. 1268-1276. 1994. |
Fontaine, M.D., Arthur B., et al., “Prototype Stent: Invivo Swine Studies in the Biliary System1”, p. 101-105, Journal of Vascular and Interventional Radiology; Jan.-Feb. 1997; vol. 8, No. 1. |
Fontaine, M.D., Arthur B., et al., “Vascular Stent Prototype; Results of Preclinical Evaluation”, p. 29-34; Technical Developments and Instrumentation; Jan.-Feb. 1996, vol. 7, No. 1. |
H.R. Andersen “History of Percutaneous Aortic Valve Prosthesis,” Herz No. 34. pp. 343-346. 2009. |
H.R. Andersen, et al. “Transluminal Implantation of Artificial Heart Valve. Description of a New Expandable Aortic Valve and Initial Results with implantation by Catheter Technique in Closed Chest Pig,” European Heart Journal, No. 13. pp. 704-708. 1992. |
Patrick W. Serruys, Nicolo Piazza, Alain Cribier, John Webb, Jean-Claude Laborde, Peter de Jaegere, “Transcatheter Aortic Valve Implantation: Tips and Tricks to Avoid Failure”; we file the table of contents and pp. 18 to 39 (Chapter 2) and pp. 102-114 (Chapter 8); the publication date according to the “Library of Congress Cataloging-in-Publication Data” is Nov. 24, 2009. |
Pavcnik, et al. “Development and initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology, vol. 183, No. 1. pp. 151-154. 1992. |
Ross, “Aortic Valve Surgery,” At a meeting of the Council on Aug. 4, 1966. pp. 192-197. |
Sabbah, et al. “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Journal of Cardiac Surgery, vol. 4, No. 4. pp. 302-309. 1989. |
Uchida, “Modifications of Gianturco Expandable Wire Stents,” American Journal of Roentgenology, vol. 150. pp. 1185-1187. 1986. |
Walther T, Dehdashtian MM, Khanna R, Young E, Goldbrunner PJ, Lee W. Trans-catheter valve-in-valve implantation: in vitro hydrodynamic performance of the SAPIEN+cloth trans-catheter heart valve in the Carpentier-Edwards Perimount valves. Eur J Cardiothorac Surg. 2011;40(5):1120-6. Epub Apr. 7, 2011. |
Wheatley, “Valve Prostheses,” Operative Surgery, 4th ed. pp. 415-424. 1986. |
Number | Date | Country | |
---|---|---|---|
63139514 | Jan 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2022/012873 | Jan 2022 | WO |
Child | 18316056 | US |